We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+12.51%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.86B
AUM Growth
+$246M
Cap. Flow
+$82.5M
Cap. Flow %
4.43%
Top 10 Hldgs %
34.22%
Holding
1,158
New
69
Increased
498
Reduced
498
Closed
91

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$12.9M
2
MSFT icon
Microsoft
MSFT
+$12.5M
3
NVDA icon
NVIDIA
NVDA
+$7.63M
4
AMZN icon
Amazon
AMZN
+$5.14M
5
TSLA icon
Tesla
TSLA
+$4.94M

Sector Composition

Rank Sector Weight
1 Technology 37.9%
2 Healthcare 15.37%
3 Consumer Discretionary 12.43%
4 Communication Services 8.94%
5 Energy 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTYX
576
DELISTED
Ventyx Biosciences
VTYX
$405K 0.02%
12,350
+3,414
+38% +$118K
FLG
577
Flagstar Bank National Association
FLG
$5.77B
$404K 0.02%
11,986
-5,453
-31% -$165K
GRMN
578
Garmin
GRMN
$46.9B
$402K 0.02%
3,852
+1,274
+49% +$130K
BBY icon
579
Best Buy
BBY
$18B
$401K 0.02%
4,897
+1,586
+48% +$118K
WSO icon
580
Watsco Inc
WSO
$14.9B
$400K 0.02%
1,049
-91
-8% -$30.9K
KR icon
581
Kroger
KR
$34.8B
$400K 0.02%
8,514
+46
+0.5% +$2.19K
SSB icon
582
SouthState Bank Corp
SSB
$10.3B
$399K 0.02%
6,061
-501
-8% -$33.4K
RDN icon
583
Radian Group
RDN
$5.14B
$398K 0.02%
15,725
-1,959
-11% -$48.2K
PCRX icon
584
Pacira BioSciences
PCRX
$1.02B
$394K 0.02%
9,843
-524
-5% -$21.7K
PAC icon
585
Grupo Aeroportuario del Pacifico
PAC
$12.9B
$394K 0.02%
2,205
+375
+20% +$68.3K
BCS icon
586
Barclays
BCS
$94.1B
$393K 0.02%
49,964
-9,562
-16% -$74K
TTWO icon
587
Take-Two Interactive
TTWO
$43B
$392K 0.02%
2,666
+456
+21% +$59.6K
MTB icon
588
M&T Bank
MTB
$36.2B
$391K 0.02%
3,160
-409
-11% -$49.5K
FICO icon
589
Fair Isaac
FICO
$28.7B
$388K 0.02%
480
+122
+34% +$91.5K
VRSN icon
590
VeriSign
VRSN
$25.3B
$387K 0.02%
1,713
+434
+34% +$95.7K
SBAC icon
591
SBA Communications
SBAC
$18.4B
$387K 0.02%
1,669
-22
-1% -$5.26K
EWBC icon
592
East-West Bancorp
EWBC
$17.9B
$385K 0.02%
7,296
-925
-11% -$46.9K
KURA icon
593
Kura Oncology
KURA
$922M
$385K 0.02%
36,393
-14,779
-29% -$175K
ALDX icon
594
Aldeyra Therapeutics
ALDX
$91.7M
$385K 0.02%
+45,877
New +$452K
AVY icon
595
Avery Dennison
AVY
$12.3B
$384K 0.02%
2,238
+107
+5% +$18.3K
PNW icon
596
Pinnacle West Capital
PNW
$12.9B
$384K 0.02%
4,717
-427
-8% -$34.1K
DO
597
DELISTED
Diamond Offshore Drilling, Inc.
DO
$384K 0.02%
26,961
+2,067
+8% +$24.5K
SNY icon
598
Sanofi
SNY
$104B
$383K 0.02%
7,111
-1,361
-16% -$73.2K
MANH icon
599
Manhattan Associates
MANH
$8.97B
$382K 0.02%
1,913
-274
-13% -$47.6K
CF icon
600
CF Industries
CF
$19.2B
$382K 0.02%
5,500
+238
+5% +$16.6K

Similar funds

Profund Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Profund Advisors held 1,158 positions worth $1.86B, up 15% from $1.62B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Profund Advisors deployed $82.5M of net new capital in Q2 2023, opening 69 new positions and adding to 498 existing holdings. Its largest new stake was Biomea Fusion: 24,713 shares worth $542K.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Fiserv Inc, an estimated $3.11M trimmed.

  • Profund Advisors's largest Q2 2023 buy was Biomea Fusion: 24,713 shares worth $542K.
  • Profund Advisors added most to Apple in Q2 2023, an estimated $12.9M increase.
  • Profund Advisors's biggest Q2 2023 reduction was Fiserv Inc, cutting an estimated $3.11M.
  • Profund Advisors fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $1.23M.
  • Profund Advisors's ten largest holdings make up 34% of its $1.86B portfolio in Q2 2023.
  • Profund Advisors opened 69 new positions and closed 91 in Q2 2023.
  • Profund Advisors's portfolio value rose 15% quarter-over-quarter to $1.86B.

Based on Profund Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.